Search filters

List of works by Timothy A Yap

Clinical BRCA1/2 reversion analysis identifies hotspot mutations and predicted neoantigens associated with therapy resistance

scientific article published on 22 July 2020

First-in-Human Trial of the Oral Ataxia Telangiectasia and Rad3-Related Inhibitor BAY 1895344 in Patients with Advanced Solid Tumors

scientific article published on 28 September 2020

Molecular profiling of metastatic bladder cancer early-phase clinical trial participants predicts patient outcomes

scientific article published on 15 December 2020

PARP inhibition - opportunities in pancreatic cancer

scientific article published on 01 October 2019

PRMT1-dependent regulation of RNA metabolism and DNA damage response sustains pancreatic ductal adenocarcinoma

scientific article published on 30 July 2021

Phase I trial of the poly(ADP-ribose) polymerase (PARP) inhibitor olaparib and AKT inhibitor capivasertib in patients with BRCA1/2 and non-BRCA1/2 mutant cancers

scientific article published on 12 June 2020

Safety and clinical activity of a new anti-PD-L1 antibody as monotherapy or combined with targeted therapy in advanced solid tumors: the PACT phase Ia/Ib trial

scientific article published on 23 November 2020

The National Lung Matrix Trial of personalized therapy in lung cancer

scientific article published on 15 July 2020

Triplet therapy with palbociclib, taselisib and fulvestrant in PIK3CA mutant breast cancer and doublet palbociclib and taselisib in pathway mutant solid cancers

scientific article published on 21 September 2020